Julen
Oyarzabal Santamarina
Investigador hasta 2018
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (4)
2019
-
Targeting CB1 and GPR55 Endocannabinoid Receptors as a Potential Neuroprotective Approach for Parkinson’s Disease
Molecular Neurobiology, Vol. 56, Núm. 8, pp. 5900-5910
2016
-
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinson's disease
Brain, Behavior, and Immunity, Vol. 57, pp. 94-105
2014
-
Phosphodiesterase inhibition in cognitive decline
Journal of Alzheimer's Disease, Vol. 42, pp. S561-S573
2013
-
Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD
Neuropharmacology, Vol. 64, pp. 114-123